1. Home
  2. NOTV vs XOS Comparison

NOTV vs XOS Comparison

Compare NOTV & XOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NOTV
  • XOS
  • Stock Information
  • Founded
  • NOTV 1974
  • XOS 2016
  • Country
  • NOTV United States
  • XOS United States
  • Employees
  • NOTV 2055
  • XOS N/A
  • Industry
  • NOTV Biotechnology: Pharmaceutical Preparations
  • XOS Construction/Ag Equipment/Trucks
  • Sector
  • NOTV Health Care
  • XOS Consumer Discretionary
  • Exchange
  • NOTV Nasdaq
  • XOS Nasdaq
  • Market Cap
  • NOTV 40.4M
  • XOS 37.9M
  • IPO Year
  • NOTV 1997
  • XOS N/A
  • Fundamental
  • Price
  • NOTV $1.45
  • XOS $4.80
  • Analyst Decision
  • NOTV Buy
  • XOS Buy
  • Analyst Count
  • NOTV 3
  • XOS 4
  • Target Price
  • NOTV $5.25
  • XOS $15.00
  • AVG Volume (30 Days)
  • NOTV 155.5K
  • XOS 14.8K
  • Earning Date
  • NOTV 08-08-2024
  • XOS 11-07-2024
  • Dividend Yield
  • NOTV N/A
  • XOS N/A
  • EPS Growth
  • NOTV N/A
  • XOS N/A
  • EPS
  • NOTV N/A
  • XOS N/A
  • Revenue
  • NOTV $501,062,000.00
  • XOS $63,769,000.00
  • Revenue This Year
  • NOTV N/A
  • XOS $78.99
  • Revenue Next Year
  • NOTV $8.69
  • XOS $69.22
  • P/E Ratio
  • NOTV N/A
  • XOS N/A
  • Revenue Growth
  • NOTV N/A
  • XOS 119.67
  • 52 Week Low
  • NOTV $1.23
  • XOS $4.62
  • 52 Week High
  • NOTV $11.42
  • XOS $15.00
  • Technical
  • Relative Strength Index (RSI)
  • NOTV 41.98
  • XOS 32.95
  • Support Level
  • NOTV $1.23
  • XOS $4.63
  • Resistance Level
  • NOTV $1.46
  • XOS $4.82
  • Average True Range (ATR)
  • NOTV 0.13
  • XOS 0.25
  • MACD
  • NOTV 0.01
  • XOS 0.01
  • Stochastic Oscillator
  • NOTV 46.08
  • XOS 14.36

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery and development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, it supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through the RMS segment, it offers access to a wide range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas. It earns maximum revenue from RMS Segment.

About XOS Xos Inc.

Xos Inc is an electric mobility company. It designs and develops fully electric battery mobility systems specifically for commercial fleets. The company's primary focus is on medium- and heavy-duty commercial vehicles that travel on last mile routes. The company leverages its proprietary technologies to provide commercial fleets zero emission vehicles that are easier to maintain and more cost-efficient on a total cost of ownership basis than internal combustion engine and commercial EV counterparts.

Share on Social Networks: